Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Bulletin Du Cancer
|
August 12, 2023
[French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network]
Christelle de la Fouchardière, Magalie Haissaguerre, Myriam Decaussin-Petrucci, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2021
Impact of COVID-19 on healthcare organisation and cancer outcomes
Aurelie Bardet, Alderic M Fraslin, Jamila Marghadi, et al.
Cancer Medicine
|
August 16, 2022
Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective study
Sarah Watson, Benjamin Verret, Stanislas Ropert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of <i>CTNNB1</i> Mutational Status
Olivier Mir, Charles Honoré, Ali N Chamseddine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2022
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients
Lambros Tselikas, Antoine Dardenne, Thierry de Baere, et al.
Endocrine-Related Cancer
|
August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study
Julien Hadoux, Thomas Walter, Christina Kanaan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 6, 2025
Characterization, Prognosis, and Treatment of Patients With Locally Advanced or Metastatic Thymic Neuroendocrine Tumor: A Retrospective Study of the French GTE, ENDOCAN RENATEN, and RYTHMIC Networks
Sarah Fodil-Cherif, Julien Hadoux, Olaf Mercier, et al.
The British Journal of Surgery
|
July 14, 2022
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study
Sébastien Gaujoux, Guillaume L Martin, Eric Mirallié, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Bulletin Du Cancer
|
August 12, 2023
[French recommendations for malignant pheochromocytomas and paragangliomas by the national ENDOCAN-COMETE network]
Christelle de la Fouchardière, Magalie Haissaguerre, Myriam Decaussin-Petrucci, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2021
Impact of COVID-19 on healthcare organisation and cancer outcomes
Aurelie Bardet, Alderic M Fraslin, Jamila Marghadi, et al.
Cancer Medicine
|
August 16, 2022
Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective study
Sarah Watson, Benjamin Verret, Stanislas Ropert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of <i>CTNNB1</i> Mutational Status
Olivier Mir, Charles Honoré, Ali N Chamseddine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2022
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients
Lambros Tselikas, Antoine Dardenne, Thierry de Baere, et al.
Endocrine-Related Cancer
|
August 3, 2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study
Julien Hadoux, Thomas Walter, Christina Kanaan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 6, 2025
Characterization, Prognosis, and Treatment of Patients With Locally Advanced or Metastatic Thymic Neuroendocrine Tumor: A Retrospective Study of the French GTE, ENDOCAN RENATEN, and RYTHMIC Networks
Sarah Fodil-Cherif, Julien Hadoux, Olaf Mercier, et al.
The British Journal of Surgery
|
July 14, 2022
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study
Sébastien Gaujoux, Guillaume L Martin, Eric Mirallié, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
Julien Hadoux, Christina Kanaan, Alice Durand, et al.
Signal Transduction and Targeted Therapy
|
March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Antonin Levy, Daphné Morel, Matthieu Texier, et al.
Page
of 10